Navigation Links
ResMed Takes Action to Enforce Patents Against BMC and 3B
Date:6/5/2013

SAN DIEGO, June 5, 2013 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has filed a lawsuit in U.S. Federal Court, Southern District of California in San Diego, to stop infringement of ResMed patents.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

ResMed filed the action against Chinese medical device manufacturer BMC Medical Co., Ltd. and its U.S. sales subsidiary, 3B Products, LLC, asserting patent infringement by:

  • The RESmart CPAP and RESmart Auto CPAP devices
  • The Willows nasal pillows patient interface and the iVolve nasal mask.
  • ResMed further filed a request to add BMC to its pending International Trade Commission (ITC) case against Taiwanese manufacturer APEX to stop the importation and sales of these products in the United States.

    The ITC case against APEX, filed March 27, 2013, also named Medical Depot, Inc., doing business as Drive Medical Design and Manufacturing, in the patent infringement case. On May 30, Drive Medical Design and Manufacturing filed papers stating that it is prepared to enter into a consent decree promising to stop importation and sales of the APEX products named in the ITC proceeding. 

    "ResMed has built its unique market differentiation by investing in superior technology and medical science-driven innovation for sleep-disordered breathing therapy," said ResMed global general counsel and chief administrative officer David Pendarvis . "We will continue to defend our proprietary technology by enforcing our patents."

    About ResMed:
    ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.

    Contacts:For News MediaFor the Finance and Investor CommunityGretchen GriswoldConstance BienfaitDirector, Global Corporate CommunicationsDirector, Investor RelationsO: 858-836-6789O: 858-836-5971news@resmed.comconstance.bienfait@resmed.com


    '/>"/>
    SOURCE ResMed Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ResMed Launches SleepSeeker Online Tool to Increase Patient Engagement in Therapy for Sleep-Disordered Breathing
    2. The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering
    3. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
    4. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
    5. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
    6. ResMed Takes Action to Enforce Patents
    7. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
    8. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
    9. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
    10. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
    11. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2017)...  Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe ... from painful intercourse and other painful pelvic pain conditions such as pelvic ... ... ... Florida -based start-up company, VuVatech LLC, fills a void in the ...
    (Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
    (Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
    Breaking Medicine Technology:
    (Date:7/21/2017)... ... July 21, 2017 , ... How physicians and athletic trainers ... say researchers presenting their work at the American Orthopaedic Society for Sports ... evaluating the patterns of change in concussion symptom presentation, diagnostic tools used and ...
    (Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
    (Date:7/20/2017)... ... July 20, 2017 , ... ... IT operations analytics and application performance monitoring (APM) solutions, has expanded its ... services providers. , According to Peter Ohrenberger, sales director at Nastel, “We’ve ...
    (Date:7/20/2017)... ... 20, 2017 , ... For individuals with extended hospital stays or who are ... such facilities are specially designed to accommodate patients with a wide range of ailments ... from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, a specially designed armrest ...
    (Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... Team Type ... access to medicine for everyone affected by diabetes, is teaming up with a Microsoft ... global event kicks off on July 24th. , “Team Type 1’s mission overlaps ...
    Breaking Medicine News(10 mins):